Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]

Background: The objective of this review was to evaluate the medicinal potential of Morus alba leaves on the control of type 2 diabetes mellitus (DM2). The research question was: what is the therapeutic potential of Morus alba leaves for the control of DM2? Methods: This systematic review was based...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jorge Guillermo Morales Ramos, Ambrocio Teodoro Esteves Pairazamán, María Ema Soledad Mocarro Willis, Samuel Collantes Santisteban, Emma Caldas Herrera
Formato: article
Lenguaje:EN
Publicado: F1000 Research Ltd 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e47c8ee4fadb4d8c8573130c5125a51e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e47c8ee4fadb4d8c8573130c5125a51e
record_format dspace
spelling oai:doaj.org-article:e47c8ee4fadb4d8c8573130c5125a51e2021-11-22T12:41:06ZMedicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]2046-140210.12688/f1000research.55573.1https://doaj.org/article/e47c8ee4fadb4d8c8573130c5125a51e2021-10-01T00:00:00Zhttps://f1000research.com/articles/10-1022/v1https://doaj.org/toc/2046-1402Background: The objective of this review was to evaluate the medicinal potential of Morus alba leaves on the control of type 2 diabetes mellitus (DM2). The research question was: what is the therapeutic potential of Morus alba leaves for the control of DM2? Methods: This systematic review was based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The included studies were extracted from Scopus, Pubmed, ScienceDirect, Scielo, and Google Scholar; January 2015 to July 2021. Key search terms were MeSH and DeCS: Morus alba, mulberry, hypoglycemic agent. The inclusion criteria were: studies in rats administered Morus alba leaf extracts; studies that included the dimensions of lipidemia and glycemia; studies that included indicators such as fasting glucose, postprandial glucose, glycosylated hemoglobin, triglycerides, low-density lipoproteins, total cholesterol, and insulin resistance. Exclusion criteria: studies in which Morus alba leaves were administered with other plants; studies with other parts of the Morus alba plant; proteomic studies, cancer, duplicate studies, in vitro studies, and evaluation of included studies. All included investigations were evaluated for biases. Results: Of 253 studies found, 29 were included. The extracts of Morus alba leaves at the phytochemical level improve glucose uptake. Chlorogenic acid, isoquercitrin, and quercitrin, present in the leaves of Morus alba, have hypoglycemic properties and an ameliorating effect on diabetic nephropathy. This leaf has pharmacological effects such as glucose absorption, insulin secretion production, antioxidant and anti-inflammatory agent, antihyperglycemic and antihyperlipidemic activities, and obesity management. Conclusions: Morus alba leaves have pharmacological effects on DM2 that include glucose absorption, production of insulin secretion, antioxidant agent, antihyperglycemic and antihyperlipidemic activities, and obesity control. Beyond these results, there is a lack of studies on the potential and synergistic effects of Morus alba leaves' components, limiting the possibility of a more effective therapy using the plant's leaves.Jorge Guillermo Morales RamosAmbrocio Teodoro Esteves PairazamánMaría Ema Soledad Mocarro WillisSamuel Collantes SantistebanEmma Caldas HerreraF1000 Research LtdarticleMedicineRScienceQENF1000Research, Vol 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jorge Guillermo Morales Ramos
Ambrocio Teodoro Esteves Pairazamán
María Ema Soledad Mocarro Willis
Samuel Collantes Santisteban
Emma Caldas Herrera
Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]
description Background: The objective of this review was to evaluate the medicinal potential of Morus alba leaves on the control of type 2 diabetes mellitus (DM2). The research question was: what is the therapeutic potential of Morus alba leaves for the control of DM2? Methods: This systematic review was based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The included studies were extracted from Scopus, Pubmed, ScienceDirect, Scielo, and Google Scholar; January 2015 to July 2021. Key search terms were MeSH and DeCS: Morus alba, mulberry, hypoglycemic agent. The inclusion criteria were: studies in rats administered Morus alba leaf extracts; studies that included the dimensions of lipidemia and glycemia; studies that included indicators such as fasting glucose, postprandial glucose, glycosylated hemoglobin, triglycerides, low-density lipoproteins, total cholesterol, and insulin resistance. Exclusion criteria: studies in which Morus alba leaves were administered with other plants; studies with other parts of the Morus alba plant; proteomic studies, cancer, duplicate studies, in vitro studies, and evaluation of included studies. All included investigations were evaluated for biases. Results: Of 253 studies found, 29 were included. The extracts of Morus alba leaves at the phytochemical level improve glucose uptake. Chlorogenic acid, isoquercitrin, and quercitrin, present in the leaves of Morus alba, have hypoglycemic properties and an ameliorating effect on diabetic nephropathy. This leaf has pharmacological effects such as glucose absorption, insulin secretion production, antioxidant and anti-inflammatory agent, antihyperglycemic and antihyperlipidemic activities, and obesity management. Conclusions: Morus alba leaves have pharmacological effects on DM2 that include glucose absorption, production of insulin secretion, antioxidant agent, antihyperglycemic and antihyperlipidemic activities, and obesity control. Beyond these results, there is a lack of studies on the potential and synergistic effects of Morus alba leaves' components, limiting the possibility of a more effective therapy using the plant's leaves.
format article
author Jorge Guillermo Morales Ramos
Ambrocio Teodoro Esteves Pairazamán
María Ema Soledad Mocarro Willis
Samuel Collantes Santisteban
Emma Caldas Herrera
author_facet Jorge Guillermo Morales Ramos
Ambrocio Teodoro Esteves Pairazamán
María Ema Soledad Mocarro Willis
Samuel Collantes Santisteban
Emma Caldas Herrera
author_sort Jorge Guillermo Morales Ramos
title Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]
title_short Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]
title_full Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]
title_fullStr Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]
title_full_unstemmed Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]
title_sort medicinal properties of morus alba for the control of type 2 diabetes mellitus: a systematic review [version 1; peer review: 2 approved]
publisher F1000 Research Ltd
publishDate 2021
url https://doaj.org/article/e47c8ee4fadb4d8c8573130c5125a51e
work_keys_str_mv AT jorgeguillermomoralesramos medicinalpropertiesofmorusalbaforthecontroloftype2diabetesmellitusasystematicreviewversion1peerreview2approved
AT ambrocioteodoroestevespairazaman medicinalpropertiesofmorusalbaforthecontroloftype2diabetesmellitusasystematicreviewversion1peerreview2approved
AT mariaemasoledadmocarrowillis medicinalpropertiesofmorusalbaforthecontroloftype2diabetesmellitusasystematicreviewversion1peerreview2approved
AT samuelcollantessantisteban medicinalpropertiesofmorusalbaforthecontroloftype2diabetesmellitusasystematicreviewversion1peerreview2approved
AT emmacaldasherrera medicinalpropertiesofmorusalbaforthecontroloftype2diabetesmellitusasystematicreviewversion1peerreview2approved
_version_ 1718417647450718208